Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT02215161 · TERMINATED

Trial details

NCT number: NCT02215161
Sponsor: University of California, San Francisco
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration Levels of Testosterone Hormone-Resistant Prostate Cancer Metastatic Prostate Carcinoma in the Soft Tissue Prostate Carcinoma Metastatic in the Bone PSA Progression Stage IV Prostate Adenocarcinoma AJCC v7

Start date: 2014-09-02
Primary completion: 2017-02-15
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.